全文获取类型
收费全文 | 24156篇 |
免费 | 2402篇 |
国内免费 | 3566篇 |
出版年
2024年 | 17篇 |
2023年 | 419篇 |
2022年 | 603篇 |
2021年 | 1426篇 |
2020年 | 1215篇 |
2019年 | 1428篇 |
2018年 | 1175篇 |
2017年 | 933篇 |
2016年 | 1208篇 |
2015年 | 1738篇 |
2014年 | 2112篇 |
2013年 | 2099篇 |
2012年 | 2580篇 |
2011年 | 2383篇 |
2010年 | 1426篇 |
2009年 | 1241篇 |
2008年 | 1429篇 |
2007年 | 1143篇 |
2006年 | 996篇 |
2005年 | 815篇 |
2004年 | 675篇 |
2003年 | 552篇 |
2002年 | 461篇 |
2001年 | 296篇 |
2000年 | 267篇 |
1999年 | 250篇 |
1998年 | 189篇 |
1997年 | 153篇 |
1996年 | 121篇 |
1995年 | 133篇 |
1994年 | 98篇 |
1993年 | 75篇 |
1992年 | 83篇 |
1991年 | 75篇 |
1990年 | 61篇 |
1989年 | 62篇 |
1988年 | 37篇 |
1987年 | 29篇 |
1986年 | 19篇 |
1985年 | 39篇 |
1984年 | 18篇 |
1983年 | 16篇 |
1982年 | 12篇 |
1981年 | 5篇 |
1978年 | 2篇 |
1973年 | 1篇 |
1972年 | 1篇 |
1965年 | 1篇 |
1950年 | 2篇 |
1938年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
Brucella cell surface protein (BCSP31) is potentially useful for diagnosing brucellosis. We aimed to establish a monoclonal antibody
(MAb) against Brucella melitensis BCSP31 and to investigate its distribution in diagnosis. Soluble recombinant BCSP31 was successfully expressed and purified.
Two MAbs (1F1 and 1E5) against B. melitensis BCSP31, effective in detecting both recombinant and cellular proteins, were obtained and characterized. The MAbs did not
react with Escherichia coli, Staphylococcus aureus, Bacillus subtilis, Mycobacterium tuberculosis, or Bacillus aeruginosus, but strongly reacted with BCSP31 and B. melitensis by ELISA and Western blot analysis. We also tested different Brucella species and brucellosis using the prepared anti-BCSP31 MAbs. BCSP31 and anti-BCSP31 MAbs may play important roles in future
research in diagnosing brucellosis. 相似文献
4.
The financing channels, investors and operators of urban rail transit are becoming more and more diversified, and public private partnership pattern has been increasingly suggested in financing and investment field of urban rail transit in China. The diversification of investors of urban rail transit will no doubt lead to the diversification of operators of urban rail transit network. To legitimately distribute the cooperation profits among operators, a model is developed based on passenger’s path choice behavior by considering travel period, travel time, transfer convenience and the comprehensive proportion of different service types provided by operators. In accordance with the features of urban rail transit network and origin-destination (OD) pairs of transferring among lines of different operators, a scheme of improved rail transit network is proposed. On the basis of the algorithm of breadth-first search and depth-first search, an algorithm of searching effective paths based on backtracking and traversing along the shortest path is established by considering the factor of transfer. Taking the example of Shenzhen’s rail transit network, three typical OD pairs are selected to measure and calculate, compare and analyze by six different conditions. The result shows that travel period, travel time, transfer convenience, and service types provided by operators exert great influence on the distribution of cooperation profits. Therefore, it is advisable to comprehensively consider all of these factors to improve the accuracy of cooperation profits distribution. Moreover, the proposed algorithm can search effective paths efficiently. 相似文献
5.
Xun Qi Yonghui Yuan Ke Xu Hongshan Zhong Zhen Zhang Huan Zhai Gefei Guan Guibo Yu 《PloS one》2015,10(5)
BackgroundPeripheral artery disease (PAD), which is caused by atherosclerosis, results in progressive narrowing and occlusion of the peripheral arteries and inhibits blood flow to the lower extremities. Therapeutic angiogenesis is a promising strategy for treating ischemia caused by PAD. Nitric oxide (NO) has been shown to be a key mediator of angiogenesis. It has been demonstrated that β-cyclodextrincan stimulate vessel growth in rabbit corneas. In this study, we assessed the mechanism of action and therapeutic potential of a new angiogenic molecule, (2-hydroxypropyl)-β-cyclodextrin (2HP-β-CD).ConclusionsTherapeutic angiogenesis by 2HP-β-CD may be beneficial to patients with PAD. 相似文献
6.
Vipin Shankar Hiroki Hori Kentaro Kihira Qi Lei Hidemi Toyoda Shotaro Iwamoto Yoshihiro Komada 《PloS one》2015,10(3)
Neuroblastoma accounts for 15% of childhood cancer deaths and presents with metastatic disease of the bone and the bone marrow at diagnosis in 70% of the cases. Previous studies have shown that the Mesenchymal Stromal Cell (MSC) secretome, triggers metastases in several cancer types such as breast and prostate cancer, but the specific role of the MSC factors in neuroblastoma metastasis is unclear. To better understand the effect of MSC secretome on chemokine receptors in neuroblastoma, and its role in metastasis, we studied a panel of 20 neuroblastoma cell lines, and compared their invasive potential towards MSC-conditioned-RPMI (mRPMI) and their cytokine receptor expression profiles. Western blot analysis revealed the expression of multiple CXCR4 isoforms in neuroblastoma cells. Among the five major isoforms, the expression of the 47 kDa isoform showed significant correlation with high invasiveness. Pretreatment with mRPMI up-regulated the expression of the 47 kDa CXCR4 isoform and also increased MMP-9 secretion, expression of integrin α3 and integrin β1, and the invasive potential of the cell; while blocking CXCR4 either with AMD 3100, a CXCR4 antagonist, or with an anti-47 kDa CXCR4 neutralizing antibody decreased the secretion of MMP-9, the expression of integrin α3 and integrin β1, and the invasive potential of the cell. Pretreatment with mRPMI also protected the 47 kDa CXCR4 isoform from ubiquitination and subsequent degradation. Our data suggest a modulatory role of the MSC secretome on the expression of the 47 kDa CXCR4 isoform and invasion potential of the neuroblastoma cells to the bone marrow. 相似文献
7.
8.
Jing Liu Dongxiao Gao Juhua Dan Dan Liu Lei Peng Ruoyu Zhou Ying Luo 《Journal of cellular biochemistry》2019,120(10):16408-16415
Aging process in mammals is associated with a decline in amplitude and a long period of circadian behaviors which are regulated by a central circadian regulator in the suprachiasmatic nucleus (SCN) and local oscillators in peripheral tissues. It is unclear whether enhancing clock function can retard aging. Using fibroblasts expressing per2::lucSV and senescent cells, we revealed cycloastragenol (CAG), a natural aglycone derivative from astragaloside IV, as a clock amplitude enhancing small molecule. CAG could activate telomerase to antiaging, but no reports focused on its effects on circadian rhythm disorders in aging mice. Here we analyze the potential effects of CAG on d -galactose-induced aging mice on the circadian behavior and expression of clock genes. For this purpose, CAG (20 mg/kg orally), was administered daily to d -galactose (150 mg/kg, subcutaneous) mice model of aging for 6 weeks. An actogram analysis of free-running activity of these mice showed that CAG significantly enhances the locomotor activity. We further found that CAG increase expressions of per2 and bmal1 genes in liver and kidney of aging mouse. Furthermore, CAG enhanced clock protein BMAL1 and PER2 levels in aging mouse liver and SCN. Our results indicated that the CAG could restore the behavior of circadian rhythm in aging mice induced by d -galactose. These data of present study suggested that CAG could be used as a novel therapeutic strategy for the treatment of age-related circadian rhythm disruption. 相似文献
9.
10.
Katherina Walz Devon Cohen Paul M. Neilsen Joseph Foster II. Francesco Brancati Korcan Demir Richard Fisher Michelle Moffat Nienke E. Verbeek Kathrine Bjørgo Adriana Lo Castro Paolo Curatolo Giuseppe Novelli Clemer Abad Cao Lei Lily Zhang Oscar Diaz-Horta Juan I. Young David F. Callen Mustafa Tekin 《Human genetics》2015,134(2):181-190